论文部分内容阅读
目的:对阿奇霉素联合氨溴特罗口服液治疗儿童支原体肺炎的临床疗效进行观察和分析。方法:选用本院2011年1月至2012年12月到收治的支原体肺炎患儿86例,将他们随机分成治疗组和对照组,每组分别为43例,给予对照组患儿阿奇霉素10mg/kg.日,iv,治疗组患儿在对照组治疗方法上再加上氨溴特罗口服液,两组疗程均为五天。结果:通过统计分析,治疗组有效率为93%,对照组有效率为83.7%,两组患儿治疗后的疗效存在差异性,具有统计意义(P<0.05)。结论:采用阿奇霉素联合氨溴特罗治疗儿童支原体肺炎具有显著疗效,对儿童呼吸道可以及时、有效地控制,不良反应少,值得临床推广并应用。
Objective: To observe and analyze the clinical efficacy of azithromycin combined with ambroxol oral liquid in the treatment of mycoplasma pneumonia in children. Methods: 86 cases of mycoplasma pneumonia admitted to our hospital from January 2011 to December 2012 were randomly divided into treatment group and control group, with 43 cases in each group. The patients in control group received azithromycin 10 mg / kg Day, iv, treatment group children in the control group plus ammonia bromine oral treatment, two courses of treatment are five days. Results: Through statistical analysis, the effective rate of the treatment group was 93% and that of the control group was 83.7%. There was difference in the curative effect between the two groups after treatment, with statistical significance (P <0.05). Conclusion: The combination of azithromycin and ambroxol has a significant therapeutic effect on children with mycoplasma pneumonia. It can control the respiratory tract of children in a timely and effective way with fewer adverse reactions. It is worthy of clinical promotion and application.